Modulation of cAMP levels by high-fat diet and curcumin and regulatory effects on CD36/FAT scavenger receptor/fatty acids transporter gene expression

BioFactors

Volumn 43, Issue 1, 2017, Pages 42-53

  Zingg, Jean Marc ^a   Hasan, Syeda T ^a   Nakagawa, Kiyotaka ^a   Canepa, Elisa ^b   Ricciarelli, Roberta ^b   Villacorta, Luis ^c   Azzi, Angelo ^a   Meydani, Mohsen ^a  

^a TUFTS UNIVERSITY   (United States)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

atherosclerosis; cAMP signaling; CD36; CREB; curcumin; fat accumulation; fat metabolism; gene expression; inflammation; NRF2; obesity; PPAR

Indexed keywords

CD36 ANTIGEN; CURCUMIN; CURCUMINGLUCURONIDE; CURCUMINSULPHATE; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DEMETHOXYCURCUMIN; DIDEMETHOXYCURCUMIN; DRUG METABOLITE; FATTY ACID TRANSPORTER; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SCAVENGER RECEPTOR; TETRAHYDROCURCUMIN; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; ANTILIPEMIC AGENT; CREB1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; EMBRYO; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPOLIPEMIA; KIDNEY TISSUE; LIPID DIET; LIPID HOMEOSTASIS; MALE; MOUSE; MUSCLE TISSUE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; SHORT COURSE THERAPY; SPLEEN TISSUE; UPREGULATION; WESTERN BLOTTING; ANIMAL; BINDING SITE; C57BL MOUSE; CELL LINE; DRUG EFFECTS; GENETICS; HEK293 CELL LINE; KNOCKOUT MOUSE; LIVER; METABOLISM; NUCLEOTIDE SEQUENCE; PHOSPHORYLATION; PRECLINICAL STUDY; PROTEIN PROCESSING;

ANIMALS; ANTIGENS, CD36; BASE SEQUENCE; BINDING SITES; CELL LINE; CURCUMIN; CYCLIC AMP; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DIET, HIGH-FAT; DRUG EVALUATION, PRECLINICAL; GENE EXPRESSION; HEK293 CELLS; HUMANS; HYPOLIPIDEMIC AGENTS; LIVER; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84976867187     PISSN: 09516433     EISSN: 18728081     Source Type: Journal    
DOI: 10.1002/biof.1307     Document Type: Article

References (89)

1. Strimpakos, A. S. and Sharma, R. A. (2008) Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials. Antioxidants Redox Signal., 10, 511–545.
2. Aggarwal, B. B. (2010) Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals. Annu. Rev. Nutr., 30, 173–199.
3. Epstein, J., Sanderson, I. R., and Macdonald, T. T. (2010) Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies. Br. J. Nutr., 103, 1545–1557.
4. Shehzad, A., Ha, T., Subhan, F., and Lee, Y. S. (2011) New mechanisms and the anti-inflammatory role of curcumin in obesity and obesity-related metabolic diseases. Eur. J. Nutr., 50, 151–161.
5. Gupta, S. C., Patchva, S., Koh, W., and Aggarwal, B. B. (2012) Discovery of curcumin, a component of golden spice, and its miraculous biological activities. Clin. Exp. Pharmacol. Physiol., 39, 283–299.
6. Ejaz, A., Wu, D., Kwan, P., and Meydani, M. (2009) Curcumin inhibits adipogenesis in 3T3-L1 adipocytes and angiogenesis and obesity in C57/BL mice. J. Nutr., 139, 919–925.
7. Shin, S. K., Ha, T. Y., McGregor, R. A., and Choi, M. S. (2011) Long-term curcumin administration protects against atherosclerosis via hepatic regulation of lipoprotein cholesterol metabolism. Mol. Nutr. Food Res., 55, 1829–1840.
8. Zingg, J. M., Hasan, S. T., Cowan, D., Ricciarelli, R., Azzi, A., et al. (2012) Regulatory effects of curcumin on lipid accumulation in monocytes/macrophages. J. Cell Biochem., 113, 833–840.
9. Bradford, P. G. (2013) Curcumin and obesity. BioFactors, 39, 78–87.
10. Hasan, S. T., Zingg, J. M., Kwan, P., Noble, T., Smith, D., et al. (2014) Curcumin modulation of high fat diet-induced atherosclerosis and steatohepatosis in LDL receptor deficient mice. Atherosclerosis, 232, 40–51.
11. Zingg, J. M., Hasan, S. T, and Meydani, M. (2013) Molecular mechanisms of hypolipidemic effects of curcumin. BioFactors, 39, 101–121.
12. Kim, J. H., Park, J. M., Kim, E. K., Lee, J. O., Lee, S. K., et al. (2010) Curcumin stimulates glucose uptake through AMPK-p38 MAPK pathways in L6 myotube cells. J. Cell Physiol., 223, 771–778.
13. Um, M. Y., Hwang, K. H., Ahn, J., and Ha, T. Y. (2013) Curcumin attenuates diet-induced hepatic steatosis by activating AMP-activated protein kinase. Basic Clin. Pharmacol. Toxicol., 113, 152–157.
14. Kou, M. C., Chiou, S. Y., Weng, C. Y., Wang, L., Ho, C. T., et al. (2013) Curcuminoids distinctly exhibit antioxidant activities and regulate expression of scavenger receptors and heme oxygenase-1. Mol. Nutr. Food Res., 57, 1598–1610.
15. Chen, F. Y., Zhou, J., Guo, N., Ma, W. G., Huang, X., et al. (2015) Curcumin retunes cholesterol transport homeostasis and inflammation response in M1 macrophage to prevent atherosclerosis. Biochem. Biophys. Res. Commun., 467, 872–878.
16. Zhang, H. H., Halbleib, M., Ahmad, F., Manganiello, V. C., and Greenberg, A. S. (2002) Tumor necrosis factor-alpha stimulates lipolysis in differentiated human adipocytes through activation of extracellular signal-related kinase and elevation of intracellular cAMP. Diabetes, 51, 2929–2935.
17. Altarejos, J. Y. and Montminy, M. (2011) CREB and the CRTC co-activators: sensors for hormonal and metabolic signals. Nat. Rev. Mol. Cell Biol., 12, 141–151.
18. Tertov, V. V., Orekhov, A. N., and Smirnov, V. N. (1986) Agents that increase cellular cyclic AMP inhibit proliferative activity and decrease lipid content in cells cultured from atherosclerotic human aorta. Artery, 13, 365–372.
19. Bjornsson, O. G., Sparks, J. D., Sparks, C. E., and Gibbons, G. F. (1994) Regulation of VLDL secretion in primary culture of rat hepatocytes: involvement of cAMP and cAMP-dependent protein kinases. Eur. J. Clin. Invest., 24, 137–148.
20. Carmen, G. Y. and Victor, S. M. (2006) Signalling mechanisms regulating lipolysis. Cell Signal., 18, 401–408.
21. Diepvens, K., Westerterp, K. R., and Westerterp-Plantenga, M. S. (2007) Obesity and thermogenesis related to the consumption of caffeine, ephedrine, capsaicin, and green tea. Am. J. Physiol. Regul. Integr. Comp. Physiol., 292, R77–R85.
22. Luiken, J. J., Willems, J., Coort, S. L., Coumans, W. A., Bonen, A., et al. (2002) Effects of cAMP modulators on long-chain fatty-acid uptake and utilization by electrically stimulated rat cardiac myocytes. Biochem. J., 367, 881–887.
23. Campbell, S. E., Tandon, N. N., Woldegiorgis, G., Luiken, J. J., Glatz, J. F., et al. (2004) A novel function for fatty acid translocase (FAT)/CD36: involvement in long chain fatty acid transfer into the mitochondria. J. Biol. Chem., 279, 36235–36241.
24. Goncalves, D. A., Lira, E. C., Baviera, A. M., Cao, P., Zanon, N. M., et al. (2009) Mechanisms involved in 3',5'-cyclic adenosine monophosphate-mediated inhibition of the ubiquitin-proteasome system in skeletal muscle. Endocrinology, 150, 5395–5404.
25. Bastie, C. C., Nahle, Z., McLoughlin, T., Esser, K., Zhang, W., et al. (2005) FoxO1 stimulates fatty acid uptake and oxidation in muscle cells through CD36-dependent and -independent mechanisms. J. Biol. Chem., 280, 14222–14229.
26. Nahle, Z., Hsieh, M., Pietka, T., Coburn, C. T., Grimaldi, P. A., et al. (2008) CD36-dependent regulation of muscle FoxO1 and PDK4 in the PPAR delta/beta-mediated adaptation to metabolic stress. J. Biol. Chem., 283, 14317–14326.
27. Na, L. X., Zhang, Y. L., Li, Y., Liu, L. Y., Li, R., et al. (2011) Curcumin improves insulin resistance in skeletal muscle of rats. Nutr. Metab. Cardiovasc. Dis., 21, 526–533.
28. Park, S. J., Ahmad, F., Philp, A., Baar, K., Williams, T., et al. (2012) Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell, 148, 421–433.
29. Jeukendrup, A. E. and Randell, R. (2011) Fat burners: nutrition supplements that increase fat metabolism. Obes. Rev., 12, 841–851.
30. K. J., Strissel, Z., Stancheva, H., Miyoshi, J. W., Perfield, 2nd, J., DeFuria, Z., et al. (2007) Adipocyte death, adipose tissue remodeling, and obesity complications. Diabetes, 56, 2910–2918.
31. Schefe, J. H., Lehmann, K. E., Buschmann, I. R., Unger, T., and Funke-Kaiser, H. (2006) Quantitative real-time RT-PCR data analysis: current concepts and the novel “gene expression's CT difference” formula. J. Mol. Med., 84, 901–910.
32. Ricciarelli, R., Zingg, J. M., and Azzi, A. (2000) Vitamin E reduces the uptake of oxidized LDL by inhibiting CD36 scavenger receptor expression in cultured human aortic smooth muscle cells. Circulation, 102, 82–87.
33. Zingg, J. M., Ricciarelli, R., Andorno, E., and Azzi, A. (2002) Novel 5' exon of scavenger receptor CD36 is expressed in cultured human vascular smooth muscle cells and atherosclerotic plaques. Arterioscler. Thromb. Vasc. Biol., 22, 412–417.
34. Villacorta, L., Zhang, J., Garcia-Barrio, M. T., Chen, X. L., Freeman, B. A., et al. (2007) Nitro-linoleic acid inhibits vascular smooth muscle cell proliferation via the Keap1/Nrf2 signaling pathway. Am. J. Physiol. Heart Circ. Physiol., 293, H770–H776.
35. De Pascale, M. C., Bassi, A. M., Patrone, V., Villacorta, L., Azzi, A., et al. (2006) Increased expression of transglutaminase-1 and PPARgamma after vitamin E treatment in human keratinocytes. Arch. Biochem. Biophys., 447, 97–106.
36. Berry, D. C., Stenesen, D., Zeve, D., and Graff, J. M. (2013) The developmental origins of adipose tissue. Development, 140, 3939–3949.
37. Balstad, T. R., Carlsen, H., Myhrstad, M. C., Kolberg, M., Reiersen, H., et al. (2011) Coffee, broccoli and spices are strong inducers of electrophile response element-dependent transcription in vitro and in vivo - studies in electrophile response element transgenic mice. Mol. Nutr. Food Res., 55, 185–197.
38. Greco, D., Kotronen, A., Westerbacka, J., Puig, O., Arkkila, P., et al. (2008) Gene expression in human NAFLD. Am. J. Physiol. Gastrointest. Liver Physiol., 294, G1281–G1287.
39. Andersen, M., Lenhard, B., Whatling, C., Eriksson, P., and Odeberg, J. (2006) Alternative promoter usage of the membrane glycoprotein CD36. BMC Mol. Biol., 7, 8.
40. Howell, J. C., Chun, E., Farrell, A. N., Hur, E. Y., Caroti, C. M., et al. (2013) Global microRNA expression profiling: curcumin (diferuloylmethane) alters oxidative stress-responsive microRNAs in human ARPE-19 cells. Mol. Vision, 19, 544–560.
41. Inoue, M., Ohtake, T., Motomura, W., Takahashi, N., Hosoki, Y., et al. (2005) Increased expression of PPARgamma in high fat diet-induced liver steatosis in mice. Biochem. Biophys. Res. Commun., 336, 215–222.
42. Nakamura, M. T., Yudell, B. E., and Loor, J. J. (2014) Regulation of energy metabolism by long-chain fatty acids. Prog. Lipid Res., 53, 124–144.
43. Sundaresan, S. and Abumrad, N. A. (2015) Dietary lipids inform the gut and brain about meal arrival via CD36-mediated signal transduction. J. Nutr., 145, 2195–2200.
44. Tontonoz, P., Nagy, L., Alvarez, J. G., Thomazy, V. A., and Evans, R. M. (1998) PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell, 93, 241–252.
45. Graham, A. (2009) Curcumin adds spice to the debate: lipid metabolism in liver disease. Br. J. Pharmacol., 157, 1352–1353.
46. Shen, G., Xu, C., Hu, R., Jain, M. R., Gopalkrishnan, A., et al. (2006) Modulation of nuclear factor E2-related factor 2-mediated gene expression in mice liver and small intestine by cancer chemopreventive agent curcumin. Mol. Cancer. Ther., 5, 39–51.
47. Maruyama, A., Tsukamoto, S., Nishikawa, K., Yoshida, A., Harada, N., et al. (2008) Nrf2 regulates the alternative first exons of CD36 in macrophages through specific antioxidant response elements. Arch. Biochem. Biophys., 477, 139–145.
48. Cardozo, L. F., Pedruzzi, L. M., Stenvinkel, P., Stockler-Pinto, M. B., Daleprane, J. B., et al. (2013) Nutritional strategies to modulate inflammation and oxidative stress pathways via activation of the master antioxidant switch Nrf2. Biochimie, 95, 1525–1533.
49. Xu, Y., Ku, B., Tie, L., Yao, H., Jiang, W., et al. (2006) Curcumin reverses the effects of chronic stress on behavior, the HPA axis, BDNF expression and phosphorylation of CREB. Brain Res., 1122, 56–64.
50. Nakagawa, K., Zingg, J. M., Kim, S. H., Thomas, M. J., Dolnikowski, G. G., et al. (2014) Differential cellular uptake and metabolism of curcuminoids in monocytes/macrophages: regulatory effects on lipid accumulation. Br. J. Nutr., 1–7.
51. Misra, J., Chanda, D., Kim, D. K., Li, T., Koo, S. H., et al. (2011) Curcumin differentially regulates endoplasmic reticulum stress through transcriptional corepressor SMILE (small heterodimer partner-interacting leucine zipper protein)-mediated inhibition of CREBH (cAMP responsive element-binding protein H). J. Biol. Chem., 286, 41972–41984.
52. Liao, K. K., Wu, M. J., Chen, P. Y., Huang, S. W., Chiu, S. J., et al. (2012) Curcuminoids promote neurite outgrowth in PC12 cells through MAPK/ERK- and PKC-dependent pathways. J. Agric. Food Chem., 60, 433–443.
53. Metzler, M., Pfeiffer, E., Schulz, S. I., and Dempe, J. S. (2013) Curcumin uptake and metabolism. BioFactors, 39, 14–20
54. Li, Y. C., Wang, F. M., Pan, Y., Qiang, L. Q., Cheng, G., et al. (2009) Antidepressant-like effects of curcumin on serotonergic receptor-coupled AC-cAMP pathway in chronic unpredictable mild stress of rats. Prog. Neuropsychopharmacol. Biol. Psychiatry, 33, 435–449.
55. Abusnina, A., Keravis, T., Yougbare, I., Bronner, C., and Lugnier, C. (2011) Anti-proliferative effect of curcumin on melanoma cells is mediated by PDE1A inhibition that regulates the epigenetic integrator UHRF1. Mol. Nutr. Food Res., 55, 1677–1689.
56. Sato, O., Kuriki, C., Fukui, Y., and Motojima, K. (2002) Dual promoter structure of mouse and human fatty acid translocase/CD36 genes and unique transcriptional activation by peroxisome proliferator-activated receptor alpha and gamma ligands. J. Biol. Chem., 277, 15703–15711.
57. Qiao, L., Zou, C., Shao, P., Schaack, J., Johnson, P. F., et al. (2008) Transcriptional regulation of fatty acid translocase/CD36 expression by CCAAT/enhancer-binding protein alpha. J. Biol. Chem., 283, 8788–8795.
58. Zhou, J., Febbraio, M., Wada, T., Zhai, Y., Kuruba, R., et al. (2008) Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis. Gastroenterology, 134, 556–567.
59. Motohashi, H., Shavit, J. A., Igarashi, K., Yamamoto, M., and Engel, J. D. (1997) The world according to Maf. Nucleic Acids Res., 25, 2953–2959.
60. Postic, C., Dentin, R., and Girard, J. (2004) Role of the liver in the control of carbohydrate and lipid homeostasis. Diabetes Metab., 30, 398–408.
61. Bechmann, L. P., Hannivoort, R. A., Gerken, G., Hotamisligil, G. S., Trauner, M., et al. (2012) The interaction of hepatic lipid and glucose metabolism in liver diseases. J. Hepatol., 56, 952–964.
62. Jitrapakdee, S. (2012) Transcription factors and coactivators controlling nutrient and hormonal regulation of hepatic gluconeogenesis. Int. J. Biochem. Cell Biol., 44, 33–45.
63. Vera-Ramirez, L., Perez-Lopez, P., Varela-Lopez, A., Ramirez-Tortosa, M., Battino, M., et al. (2013) Curcumin and liver disease. BioFactors, 39, 88–100.
64. Pepino, M. Y., Kuda, O., Samovski, D., and Abumrad, N. A. (2014) Structure-function of CD36 and importance of fatty acid signal transduction in fat metabolism. Annu. Rev. Nutr., 34, 281–303.
65. Bonen, A., Han, X. X., Habets, D. D., Febbraio, M., Glatz, J. F., et al. (2007) A null mutation in skeletal muscle FAT/CD36 reveals its essential role in insulin- and AICAR-stimulated fatty acid metabolism. Am. J. Physiol. Endocrinol. Metab., 292, E1740–E1749.
66. Koonen, D. P., Jacobs, R. L., Febbraio, M., Young, M. E., Soltys, C. L., et al. (2007) Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity. Diabetes, 56, 2863–2871.
67. Yuasa-Kawase, M., Masuda, D., Yamashita, T., Kawase, R., Nakaoka, H., et al. (2011) Patients with CD36 deficiency are associated with enhanced atherosclerotic cardiovascular diseases. J. Atheroscler. Thromb.
68. Hirano, K., Kuwasako, T., Nakagawa-Toyama, Y., Janabi, M., Yamashita, S., et al. (2003) Pathophysiology of human genetic CD36 deficiency. Trends Cardiovasc. Med., 13, 136–141.
69. Nassir, F., Adewole, O. L., Brunt, E. M., and Abumrad, N. A. (2013) CD36 deletion reduces VLDL secretion, modulates liver prostaglandins, and exacerbates hepatic steatosis in ob/ob mice. J. Lipid Res., 54, 2988–2997.
70. Aitman, T. J., Glazier, A. M., Wallace, C. A., Cooper, L. D., Norsworthy, P. J., et al. (1999) Identification of CD36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat. Genet., 21, 76–83.
71. Ibrahimi, A., Bonen, A., Blinn, W. D., Hajri, T., Li, X., et al. (1999) Muscle-specific overexpression of FAT/CD36 enhances fatty acid oxidation by contracting muscle, reduces plasma triglycerides and fatty acids, and increases plasma glucose and insulin. J. Biol. Chem., 274, 26761–26766.
72. Holm, C. (2003) Molecular mechanisms regulating hormone-sensitive lipase and lipolysis. Biochem. Soc. Transact., 31, 1120–1124.
73. Schauer, I. E., Knaub, L. A., Lloyd, M., Watson, P. A., Gliwa, C., et al. (2010) CREB downregulation in vascular disease: a common response to cardiovascular risk. Arterioscler. Thromb. Vasc. Biol., 30, 733–741.
74. Gloerich, M. and Bos, J. L. (2010) Epac: defining a new mechanism for cAMP action. Annu. Rev. Pharmacol. Toxicol., 50, 355–375.
75. Schauer, I. E. and Reusch, J. E. (2009) Nonesterified fatty acid exposure activates protective and mitogenic pathways in vascular smooth muscle cells by alternate signaling pathways. Metab. Clin. Exp., 58, 319–327.
76. Tertov, V. V., Orekhov, A. N., and Smirnov, V. N. (1986) Effect of cyclic AMP on lipid accumulation and metabolism in human atherosclerotic aortic cells. Atherosclerosis, 62, 55–64.
77. Servillo, G., Della Fazia, M. A., and Sassone-Corsi, P. (2002) Coupling cAMP signaling to transcription in the liver: pivotal role of CREB and CREM. Exp. Cell Res., 275, 143–154.
78. Lee, J. H., Giannikopoulos, P., Duncan, S. A., Wang, J., Johansen, C. T., et al. (2011) The transcription factor cyclic AMP-responsive element-binding protein H regulates triglyceride metabolism. Nat. Med., 17, 812–815.
79. Zhang, C., Wang, G., Zheng, Z., Maddipati, K. R., Zhang, X., et al. (2012) Endoplasmic reticulum-tethered transcription factor cAMP responsive element-binding protein, hepatocyte specific, regulates hepatic lipogenesis, fatty acid oxidation, and lipolysis upon metabolic stress in mice. Hepatology, 55, 1070–1082.
80. Lee, M. W., Chanda, D., Yang, J., Oh, H., Kim, S. S., et al. (2010) Regulation of hepatic gluconeogenesis by an ER-bound transcription factor, CREBH. Cell Metab., 11, 331–339.
81. Budick-Harmelin, N., Anavi, S., Madar, Z., and Tirosh, O. (2012) Fatty acids-stress attenuates gluconeogenesis induction and glucose production in primary hepatocytes. Lipids Health Dis., 11, 66.
82. Lim, H. W., Lim, H. Y., and Wong, K. P. (2009) Uncoupling of oxidative phosphorylation by curcumin: implication of its cellular mechanism of action. Biochem. Biophys. Res. Commun., 389, 187–192.
83. Ishigaki, Y., Katagiri, H., Yamada, T., Ogihara, T., Imai, J., et al. (2005) Dissipating excess energy stored in the liver is a potential treatment strategy for diabetes associated with obesity. Diabetes, 54, 322–332.
84. Nedergaard, J., Golozoubova, V., Matthias, A., Asadi, A., Jacobsson, A., et al. (2001) UCP1: the only protein able to mediate adaptive non-shivering thermogenesis and metabolic inefficiency. Biochimica et biophysica Acta, 1504, 82–106.
85. Gonzalez-Muniesa, P., Milagro, F. I., Campion, J., and Martinez, J. A. (2006) Reduction in energy efficiency induced by expression of the uncoupling protein, UCP1, in mouse liver mitochondria. Int. J. Mol. Med., 17, 591–597.
86. Pu, Y., Zhang, H., Wang, P., Zhao, Y., Li, Q., et al. (2013) Dietary curcumin ameliorates aging-related cerebrovascular dysfunction through the AMPK/uncoupling protein 2 pathway. Cell Physiol. Biochem., 32, 1167–1177.
87. Moya, M., Benet, M., Guzman, C., Tolosa, L., Garcia-Monzon, C., et al. (2012) Foxa1 reduces lipid accumulation in human hepatocytes and is down-regulated in nonalcoholic fatty liver. PLoS One, 7, e30014.
88. Chavin, K. D., Yang, S., Lin, H. Z., Chatham, J., Chacko, V. P., et al. (1999) Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion. J. Biol. Chem., 274, 5692–5700.
89. Sharma, S., Zhuang, Y., Ying, Z., Wu, A., and Gomez-Pinilla, F. (2009) Dietary curcumin supplementation counteracts reduction in levels of molecules involved in energy homeostasis after brain trauma. Neuroscience, 161, 1037–1044.